Neurocrine Biosciences shares owned by Lee Munder Capital Group
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Lee Munder Capital Group
from 13F filings
Historical chart of Lee Munder Capital Group investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Lee Munder Capital Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Lee Munder Capital Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $938k | 6.8k | 137.92 |
| 2023-12-31 | $1.2M | 9.4k | 131.76 |
| 2023-09-30 | $1.1M | 9.4k | 112.50 |
| 2023-06-30 | $871k | 9.2k | 94.30 |
| 2023-03-31 | $935k | 9.2k | 101.22 |
| 2022-12-31 | $1.1M | 9.0k | 119.44 |
| 2022-09-30 | $958k | 9.0k | 106.22 |
| 2022-06-30 | $878k | 9.0k | 97.47 |
| 2022-03-31 | $845k | 9.0k | 93.81 |
| 2015-09-30 | $6.8M | 170k | 39.79 |
| 2015-06-30 | $7.0M | 147k | 47.76 |
| 2015-03-31 | $5.7M | 144k | 39.71 |